Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy (TALK)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01525420|
Recruitment Status : Completed
First Posted : February 3, 2012
Results First Posted : April 16, 2014
Last Update Posted : May 26, 2014
The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).
- end of treatment and 6-month follow-up data retention rates;
- intervention implementation quality;
- number & length of calls completed.
Comparison of each arm's implementation
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Behavioral: Acceptance Therapy (ACT) Other: Cognitive Behavioral Therapy (CBT)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||121 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||March 2013|
ACT: This is the experimental arm of the study. This included 5 weekly sessions of ACT therapy via telephone.
Behavioral: Acceptance Therapy (ACT)
Active Comparator: CBT
CBT: This is the control arm of the study. This included 5 weekly sessions of CBT therapy via telephone.
Other: Cognitive Behavioral Therapy (CBT)
- Number of Participants Who Stopped Smoking by 6 Month Post Treatment [ Time Frame: 6 months ]30-Day point prevalence abstinence at 6 months post treatment
- 7-day and 24-hour Point Prevalence Quit Rates [ Time Frame: 6-month ]7-day and 24-hour point prevalence quit rates
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01525420
|United States, Washington|
|Fred Hutchinson Cancer Research Center|
|Seattle, Washington, United States, 19024|